Cabozantinib Malate Tablets 20mg (Cabometyx® / カボメティクス錠20mg)

JPY ¥312,300

Japanese Antineoplastic Agent / Kinase Inhibitor (Cabozantinib Malate 20mg). Oral tablet for once-daily administration in renal cell carcinoma and hepatocellular carcinoma. PTP 30 tablets (10 tablets x 3). Mfd. by Takeda Pharmaceutical Company Limited, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥287,316
10 - 19 12% JPY ¥274,824
20 + 18% JPY ¥256,086
SKU: CAB-20-TAB Category:

Description

Product Overview / 商品概要

Cabometyx Tablets 20mg (カボメティクス錠20mg)
Generic: Cabozantinib Malate / カボザンチニブリンゴ酸塩
Therapeutic Category: Antineoplastic Agent / Kinase Inhibitor / 抗悪性腫瘍剤/キナーゼ阻害剤
Manufactured by: Takeda Pharmaceutical Company Limited / 武田薬品工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Cabozantinib Malate 25.34mg per tablet (equivalent to Cabozantinib 20mg) / 1錠中 カボザンチニブリンゴ酸塩として25.34mg(カボザンチニブとして20mg)
Additives: Microcrystalline cellulose, Anhydrous lactose, Hydroxypropylcellulose, Croscarmellose sodium, Light anhydrous silicic acid, Magnesium stearate, Hypromellose, Titanium oxide, Triacetin, Yellow ferric oxide / 結晶セルロース、無水乳糖、ヒドロキシプロピルセルロース、クロスカルメロースナトリウム、軽質無水ケイ酸、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、トリアセチン、黄色三二酸化鉄
Appearance: Round film-coated tablet, yellow, identification code: XL 20, diameter: approx. 5.6mm, thickness: approx. 3.8mm, weight: 83.2mg
外観: 円形のフィルムコーティング錠、黄色、識別コード:XL 20、直径:約5.6mm、厚さ:約3.8mm、質量:83.2mg

Indications / 効能効果

EN: Unresectable or metastatic renal cell carcinoma; Unresectable hepatocellular carcinoma that has progressed after cancer chemotherapy
JA: 根治切除不能又は転移性の腎細胞癌、がん化学療法後に増悪した切除不能な肝細胞癌

Dosage and Administration / 用法用量

EN: Unresectable or metastatic renal cell carcinoma: Administer 60mg of cabozantinib orally once daily on an empty stomach. Dose may be reduced based on patient condition. When used in combination with nivolumab (genetically recombinant): Administer 40mg of cabozantinib orally once daily on an empty stomach. Dose may be reduced based on patient condition. Unresectable hepatocellular carcinoma that has progressed after cancer chemotherapy: Administer 60mg of cabozantinib orally once daily on an empty stomach. Dose may be reduced based on patient condition.
JA: 根治切除不能又は転移性の腎細胞癌:通常、成人にはカボザンチニブとして1日1回60mgを空腹時に経口投与する。なお、患者の状態により適宜減量する。ニボルマブ(遺伝子組換え)と併用する場合は、通常、成人にはカボザンチニブとして1日1回40mgを空腹時に経口投与する。なお、患者の状態により適宜減量する。がん化学療法後に増悪した切除不能な肝細胞癌:通常、成人にはカボザンチニブとして1日1回60mgを空腹時に経口投与する。なお、患者の状態により適宜減量する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30200AMX00433
Sales Started: May 2020 / 2020年5月
Classification Code: 874291
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): PTP 30 tablets (10 tablets x 3) / PTP 30錠(10錠×3)
Other Available Packages (by special order): PTP 30 tablets (10 tablets x 3)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Cabozantinib Malate Tablets 20mg (Cabometyx® / カボメティクス錠20mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Cabozantinib Malate Tablets 20mg (Cabometyx®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.